We evaluated the prognostic value of hsa-miR-324-5p in PAAD and found that high expression of hsa-miR-324-5p was positively correlated with the prognosis of PAAD patients (Figure 8C), indicating that hsa-miR-324-5p is a potential regulatory miRNA for RNF169 in PAAD. The gene discussed is RNF169; the disease is pancreatic adenocarcinoma.